Cell_IDx

03/30/2022

Come visit us at AACR 2022!
Turn your fluorescent multiplex IHC panel into a chromogenic multiplex IHC panel with Cell IDx’s UltraPlex mxIHC. To learn how, visit Cell IDx’s booth #3332 at AACR 2022. https://cellidx.com/technology/technology

03/30/2022

03/30/2022

The freedom to transform your great IHC antibodies into fluorescent or chromogenic multiplex IHC staining panels using UltraTag Multiplex Labeling Kits!

03/30/2022

Mouse Fluorescent Multiplex IHC staining panels for preclinical research, the newest member of our UltraPlex technology family! Our modular format easily allows customers to build their own multiplex panel by selecting from our portfolio of biomarkers and choosing their preferred set of fluors.

05/21/2021

Cell IDx would like to recognize Bladder Cancer Awareness month and help continue the fight against this and all cancers. At Cell IDx, we continuously work to understand each tumor micro-environment in detail.

05/18/2021

Read tips from our CSO, David Schwartz, on how to optimize your data using multiplex IHC in this latest Biocompare editorial.

New tools, technologies, and techniques to streamline IHC protocols.

04/22/2021

Thrilled to partner with Leica on this exciting new application of the UltraPlex technology!
https://cellidx.com/documents/Cell_IDx_Leica_Partnership_announcement_for_Cell_IDx_News_4.22.21.pdf

01/26/2021

Cell IDx is excited to preview the release of our new UltraPlex chromogenic multiplex IHC product line at the Leica Biosystems Multiplex Users’ Meeting on February 2-3rd. We would like to invite everyone to the event to hear Dr. Helen Snyder introduce this new technology. Please register at https://lnkd.in/dwu9mYf

01/26/2021

Industry veterans Gary Magnant, Karen Padgett & Cheri Walker To Join the Cell IDx Board of Directors.

Cell IDx, providers of advanced multiplex immunoassay technologies, today announced that industry leaders Gary Magnant, Karen Padgett, and Cheri Walker (in photo, respectively) will join Cell IDx’s Board of Directors. “We are delighted to welcome Gary, Karen, and Cheri to our Board of Directors,” shared David Schwartz, Cell IDx’s Founder and CEO. “Gary Magnant is a serial entrepreneur who has founded multiple technology companies, served on numerous boards, and has raised significant investment capital. Karen Padgett is the founder and former CEO of Novus Biologicals, a global life sciences company that was acquired by BioTechne in 2014. Karen grew Novus from a company of one and revenues of $0 to an international company with revenues in excess of $20 million. Cheri Walker has over two decades of experience in corporate development in life science tools and diagnostics companies including Abcam, Charles River, Invitrogen, and Qiagen and is currently CEO of Rhinostics. Their experience will be key as Cell IDx expands its range of multiplex immunoassay solutions for pharma, research, and clinical applications.”